[144] Tempus AI, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 summary: The filing notifies a proposed sale of 20,000 shares of common stock of the issuer, with an aggregate market value of $1,516,650, expected to be sold on 08/26/2025 through Citigroup Global Markets Inc. The securities were acquired on 01/30/2025 as a venture capital distribution from Revolution Growth III, comprising 130,756 shares received and paid on that date. The issuer has 168,683,769 shares outstanding per the form. The filing also reports a prior sale in the past three months: Theodore Leonsis sold 44,000 shares on 08/13/2025 for $3,075,786.12. The signer certifies they are unaware of undisclosed material adverse information.

Positive

• Clear disclosure of proposed sale details including broker, share count, and aggregate market value
• Acquisition source identified as a venture capital distribution from Revolution Growth III
• Brokered sale via Citigroup Global Markets indicates use of a regulated intermediary
• Signer attestation confirms no known undisclosed material adverse information

Negative

• Insider selling in the recent period: Theodore Leonsis sold 44,000 shares on 08/13/2025
• Limited context on the identity of the person filing the notice and motives for sale (only information provided in form)

Insights

Securities Analyst

TL;DR: Small planned sale disclosed; recent insider sale recorded; transaction size appears modest relative to outstanding shares.

The filing reports a proposed brokered sale of 20,000 common shares valued at $1.52 million, executed through Citigroup. Acquisition via a venture capital distribution earlier in 2025 indicates secondary-market liquidity for VC holders. The issuer's outstanding shares (168.7 million) make the proposed sale a very small fraction of float, suggesting limited direct market impact. The recent sale by Theodore Leonsis (44,000 shares) is disclosed, which is relevant to monitoring insider activity but is not, by itself, large relative to total shares outstanding.

Corporate Governance Expert

TL;DR: Filing provides routine compliance disclosure; includes representation about absence of undisclosed material information.

The Form 144 contains the standard attestation that the seller does not possess undisclosed material information and documents the use of a registered broker for execution. The origin of the shares as a venture capital distribution is clearly stated, which helps trace beneficial ownership changes. From a governance perspective, the filing meets disclosure expectations for proposed insider or affiliate sales but does not on its face indicate governance concerns or undisclosed events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Citigroup Global Markets Inc 388 Greenwich Street New York NY 10013	20000	1516650.00	168683769	08/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/30/2025	Venture capital distribution	Revolution Growth III			130756	01/30/2025	venture capital distribution

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Theodore Leonsis 112231 River View Drive Potomac MD 20854	Common Stock	08/13/2025	44000	3075786.12

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for TEM disclose about the proposed sale?

The form discloses a proposed sale of 20,000 common shares valued at $1,516,650, to be sold on 08/26/2025 through Citigroup Global Markets Inc.

How and when were the securities to be sold on Form 144 acquired?

The securities were acquired on 01/30/2025 as a venture capital distribution from Revolution Growth III, totaling 130,756 shares.

Did the filer report any recent sales in the past three months?

Yes. The filing reports that Theodore Leonsis sold 44,000 shares on 08/13/2025 for $3,075,786.12.

What broker is handling the proposed sale in the Form 144?

The proposed sale is to be handled by Citigroup Global Markets Inc at 388 Greenwich Street, New York, NY.

Does the Form 144 include a statement about undisclosed material information?

Yes. The signer represents by signing that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.